Pei-Jer Chen

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 39

Top Venues

Journal of proteome research

Journal of gastroenterology and hepatology

Hepatology (Baltimore, Md.)

Journal of clinical medicine

National Taiwan University

University of Pennsylvania (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

National Taiwan University

Taiwan

Professor :: Graduate Institute of Microbiology, College of Medicine

National Taiwan University

Taiwan

Professor :: Graduate Institute of Clinical Medicine, College of Medicine

National Taiwan University Hospital

Taiwan

Attending Physician :: Division of Gastroenterology and Hepatology, Department of Internal Medicine

National Taiwan University Hospital

Taiwan

Director :: Department of Medical Research

National Taiwan University

Taiwan

Chairman :: Graduate Institute of Clinical Medicine, Medical College

National Taiwan University Hospital

Taiwan

Director :: Hepatitis Research Center

Education History

University of Pennsylvania

United States

PHD :: Department of Pathology, Medical School

Publications

Xian-Yang Qin, Yohei Shirakami, Masao Honda, Shiou-Hwei Yeh, Kazushi Numata, Ya-Yun Lai, Chiao-Ling Li, Feifei Wei, Yali Xu, Kenji Imai, Koji Takai, Makoto Chuma, Nagisa Komatsu, Yutaka Furutani, Luc Gailhouste, Hiroshi Aikata, Kazuaki Chayama, Masaru Enomoto, Ryosuke Tateishi, Kazunori Kawaguchi, Tatsuya Yamashita, Shuichi Kaneko, Katsuya Nagaoka, Motohiko Tanaka, Yutaka Sasaki, Yasuhito Tanaka, Hideo Baba, Kouichi Miura, Sae Ochi, Takahiro Masaki, Soichi Kojima, Tomokazu Matsuura, Masahito Shimizu, Pei-Jer Chen, Hisataka Moriwaki, Harukazu Suzuki
Serum MYCN as a predictive biomarker of prognosis and therapeutic response in the prevention of hepatocellular carcinoma recurrence. International journal of cancer 155 (3) (2024)
Tiara Pradita, Yi-Ju Chen, Tung-Hung Su, Kun-Hao Chang, Pei-Jer Chen, Yi-Ju Chen
Data Independent Acquisition Mass Spectrometry Enhanced Personalized Glycosylation Profiling of Haptoglobin in Hepatocellular Carcinoma. Journal of proteome research (2024)
Tiara Pradita, Yi-Ju Chen, Tung-Hung Su, Kun-Hao Chang, Pei-Jer Chen, Yi-Ju Chen
Data Independent Acquisition Mass Spectrometry Enhanced Personalized Glycosylation Profiling of Haptoglobin in Hepatocellular Carcinoma. Journal of proteome research (2024)
Tiara Pradita, Yi-Ju Chen, Tung-Hung Su, Kun-Hao Chang, Pei-Jer Chen, Yi-Ju Chen
Data Independent Acquisition Mass Spectrometry Enhanced Personalized Glycosylation Profiling of Haptoglobin in Hepatocellular Carcinoma. Journal of proteome research 23 (8) (2024)
Tiara Pradita, Yi-Ju Chen, Tung-Hung Su, Kun-Hao Chang, Pei-Jer Chen, Yi-Ju Chen
Data Independent Acquisition Mass Spectrometry Enhanced Personalized Glycosylation Profiling of Haptoglobin in Hepatocellular Carcinoma. Journal of proteome research 23 (8) (2024)
Xian-Yang Qin, Yohei Shirakami, Masao Honda, Shiou-Hwei Yeh, Kazushi Numata, Ya-Yun Lai, Chiao-Ling Li, Feifei Wei, Yali Xu, Kenji Imai, Koji Takai, Makoto Chuma, Nagisa Komatsu, Yutaka Furutani, Luc Gailhouste, Hiroshi Aikata, Kazuaki Chayama, Masaru Enomoto, Ryosuke Tateishi, Kazunori Kawaguchi, Tatsuya Yamashita, Shuichi Kaneko, Katsuya Nagaoka, Motohiko Tanaka, Yutaka Sasaki, Yasuhito Tanaka, Hideo Baba, Kouichi Miura, Sae Ochi, Takahiro Masaki, Soichi Kojima, Tomokazu Matsuura, Masahito Shimizu, Pei-Jer Chen, Hisataka Moriwaki, Harukazu Suzuki
Serum MYCN as a predictive biomarker of prognosis and therapeutic response in the prevention of hepatocellular carcinoma recurrence. International journal of cancer (2024)
Pei-Jer Chen
Challenges for hepatitis B control in Asia-Pacific areas: Consolidating vaccination and rolling-out antiviral therapies. Journal of gastroenterology and hepatology 39 (6) (2024)
Pei-Jer Chen
Challenges for hepatitis B control in Asia-Pacific areas: Consolidating vaccination and rolling-out antiviral therapies. Journal of gastroenterology and hepatology (2024)
Xian-Yang Qin, Yohei Shirakami, Masao Honda, Shiou-Hwei Yeh, Kazushi Numata, Ya-Yun Lai, Chiao-Ling Li, Feifei Wei, Yali Xu, Kenji Imai, Koji Takai, Makoto Chuma, Nagisa Komatsu, Yutaka Furutani, Luc Gailhouste, Hiroshi Aikata, Kazuaki Chayama, Masaru Enomoto, Ryosuke Tateishi, Kazunori Kawaguchi, Tatsuya Yamashita, Shuichi Kaneko, Katsuya Nagaoka, Motohiko Tanaka, Yutaka Sasaki, Yasuhito Tanaka, Hideo Baba, Kouichi Miura, Sae Ochi, Takahiro Masaki, Soichi Kojima, Tomokazu Matsuura, Masahito Shimizu, Pei-Jer Chen, Hisataka Moriwaki, Harukazu Suzuki
Serum MYCN as a predictive biomarker of prognosis and therapeutic response in the prevention of hepatocellular carcinoma recurrence. International journal of cancer 155 (3) (2024)
Yu-Ping Chang, Chen-Hua Liu, Chiuan-Bo Huang, Ji-Yuh Lee, Chun-Jen Liu, Tung-Hung Su, Shang-Chin Huang, Tai-Chung Tseng, Pei-Jer Chen, Jia-Horng Kao
Serum Mac-2 binding protein glycosylation isomer dynamics in patients achieving sustained virologic response for hepatitis C virus. Journal of gastroenterology and hepatology (2024)
Tiara Pradita, Yi-Ju Chen, Tung-Hung Su, Kun-Hao Chang, Pei-Jer Chen, Yi-Ju Chen
Data Independent Acquisition Mass Spectrometry Enhanced Personalized Glycosylation Profiling of Haptoglobin in Hepatocellular Carcinoma. Journal of proteome research 23 (8) (2024)
Pei-Jer Chen
Challenges for hepatitis B control in Asia-Pacific areas: Consolidating vaccination and rolling-out antiviral therapies. Journal of gastroenterology and hepatology 39 (6) (2024)
Feng-Pai Tsai, Tung-Hung Su, Shang-Chin Huang, Tai-Chung Tseng, Shih-Jer Hsu, Sih-Han Liao, Chun-Ming Hong, Chen-Hua Liu, Hung-Chih Yang, Chun-Jen Liu, Pei-Jer Chen, Jia-Horng Kao
Outcomes of radiofrequency ablation for hepatocellular carcinoma with concurrent steatotic liver disease. Cancer (2024)
Pei-Jer Chen
Challenges for hepatitis B control in Asia-Pacific areas: Consolidating vaccination and rolling-out antiviral therapies. Journal of gastroenterology and hepatology 39 (6) (2024)
Albert Qin, Chang-Ru Wu, Ming-Chih Ho, Chan-Yen Tsai, Pei-Jer Chen
Sequential Therapy with Ropeginterferon Alfa-2b and Anti-Programmed Cell Death 1 Antibody for Inhibiting the Recurrence of Hepatitis B-Related Hepatocellular Carcinoma: From Animal Modeling to Phase I Clinical Results. International journal of molecular sciences 25 (1) (2023)
Albert Qin, Chang-Ru Wu, Ming-Chih Ho, Chan-Yen Tsai, Pei-Jer Chen
Sequential Therapy with Ropeginterferon Alfa-2b and Anti-Programmed Cell Death 1 Antibody for Inhibiting the Recurrence of Hepatitis B-Related Hepatocellular Carcinoma: From Animal Modeling to Phase I Clinical Results. International journal of molecular sciences 25 (1) (2023)
Chen-Hua Liu, Yu-Jen Fang, Chun-Jen Liu, Tung-Hung Su, Shang-Chin Huang, Tai-Chung Tseng, Jo-Hsuan Wu, Pei-Jer Chen, Jia-Horng Kao
Splenic Arterial Pulsatility Index to Predict Hepatic Fibrosis in Hemodialysis Patients with Chronic Hepatitis C Virus Infection. Journal of clinical medicine 12 (5) (2023)
Chen-Hua Liu, Yu-Jen Fang, Chun-Jen Liu, Tung-Hung Su, Shang-Chin Huang, Tai-Chung Tseng, Jo-Hsuan Wu, Pei-Jer Chen, Jia-Horng Kao
Splenic Arterial Pulsatility Index to Predict Hepatic Fibrosis in Hemodialysis Patients with Chronic Hepatitis C Virus Infection. Journal of clinical medicine 12 (5) (2023)
Chen-Hua Liu, Yu-Jen Fang, Chun-Jen Liu, Tung-Hung Su, Shang-Chin Huang, Tai-Chung Tseng, Jo-Hsuan Wu, Pei-Jer Chen, Jia-Horng Kao
Splenic Arterial Pulsatility Index to Predict Hepatic Fibrosis in Hemodialysis Patients with Chronic Hepatitis C Virus Infection. Journal of clinical medicine 12 (5) (2023)
Albert Qin, Chang-Ru Wu, Ming-Chih Ho, Chan-Yen Tsai, Pei-Jer Chen
Sequential Therapy with Ropeginterferon Alfa-2b and Anti-Programmed Cell Death 1 Antibody for Inhibiting the Recurrence of Hepatitis B-Related Hepatocellular Carcinoma: From Animal Modeling to Phase I Clinical Results. International journal of molecular sciences 25 (1) (2023)
Jui-Hung Tai, Hsiao-Yu Sun, Yi-Cheng Tseng, Guanghao Li, Sui-Yuan Chang, Shiou-Hwei Yeh, Pei-Jer Chen, Shu-Miaw Chaw, Hurng-Yi Wang
Contrasting Patterns in the Early Stage of SARS-CoV-2 Evolution between Humans and Minks. Molecular biology and evolution 39 (9) (2022)
Chen-Hua Liu, Hsin-Yun Sun, Cheng-Yuan Peng, Szu-Min Hsieh, Sheng-Shun Yang, Wei-Yu Kao, Yu-Lueng Shih, Chih-Lin Lin, Chun-Jen Liu, Wang-Huei Sheng, Yi-Chun Lo, Wen-Chun Liu, Jo-Hsuan Wu, Tung-Hung Su, Tai-Chung Tseng, Pei-Jer Chen, Chien-Ching Hung, Jia-Horng Kao
Hepatitis C Virus Reinfection in People With HIV in Taiwan After Achieving Sustained Virologic Response With Antiviral Treatment: The RECUR Study. Open forum infectious diseases 9 (8) (2022)
Chang-Ru Wu, Hyun-Jin Kim, Cheng-Pu Sun, Chen-Yen Chung, You-Yu Lin, Mi-Hua Tao, Jung-Hwan Kim, Ding-Shinn Chen, Pei-Jer Chen
Mapping the conformational epitope of a therapeutic monoclonal antibody against HBsAg by in vivo selection of HBV escape variants. Hepatology (Baltimore, Md.) 76 (1) (2022)
Chen-Hua Liu, Chun-Jen Liu, Tung-Hung Su, Shang-Chin Huang, Tai-Chung Tseng, Jo-Hsuan Wu, Pei-Jer Chen, Jia-Horng Kao
Serum Mac-2 Binding Protein Glycosylation Isomer to Predict the Severity of Hepatic Fibrosis in Patients with Hepatitis C Virus Infection. Diagnostics (Basel, Switzerland) 12 (11) (2022)
Chi-Yi Chen, Wan-Long Chuang, Albert Qin, Wen-Hua Zhang, Li-Ying Zhu, Guo-Qiang Zhang, Jyh-Jou Chen, Ching-Chu Lo, Xinmin Zhou, Xiaorong Mao, Jia Shang, Hsing-Tao Kuo, Wen Xie, Chien-Hung Chen, Gin-Ho Lo, Dae Won Jun, Shuangsuo Dang, Chan-Yen Tsai, Ting-Fang Wang, Hsin-Hui Lai, Kuan-Chiao Tseng, Yi-Wen Huang, Pei-Jer Chen
A Phase 3 clinical trial validating the potency and safety of an innovative, extra-long-acting interferon in chronic hepatitis C. JGH open : an open access journal of gastroenterology and hepatology 6 (11) (2022)
Yun-Yuan Chen, Chi-Te Lu, Mei-Hua Tsai, Cheng-Fen Yang, Pei-Yun Shu, Chia-Wen Wu, Jen-Wei Chen, Chi-Ming Hung, Sheng-Tang Wei, Sheng-Mou Hou, Pei-Jer Chen
Dengue Virus Ribonucleic Acid Detection Rates in Blood Donors Correlate With Local Infection Incidences During a Dengue Outbreak in Taiwan. The Journal of infectious diseases 225 (9) (2022)
Chiao-Ling Li, Shiou-Hwei Yeh, Pei-Jer Chen
Circulating Virus-Host Chimera DNAs in the Clinical Monitoring of Virus-Related Cancers. Cancers 14 (10) (2022)
Yi-Wen Huang, Albert Qin, Chan-Yen Tsai, Pei-Jer Chen
Novel Pegylated Interferon for the Treatment of Chronic Viral Hepatitis. Viruses 14 (6) (2022)
Yung-Tsung Li, Chun-Jen Liu, Jia-Horng Kao, Li-Feng Lin, Hui-Chu Tu, Chih-Chiang Wang, Po-Hsi Huang, Huei-Ru Cheng, Pei-Jer Chen, Ding-Shinn Chen, Hui-Lin Wu
Metastatic tumor antigen 1 contributes to hepatocarcinogenesis posttranscriptionally through RNA-binding function. Hepatology (Baltimore, Md.) (2022)
Chun-Ming Hong, You-Yu Lin, Chun-Jen Liu, Ya-Yun Lai, Shiou-Hwei Yeh, Hung-Chih Yang, Jia-Horng Kao, Shih-Jer Hsu, Yi-Hsiang Huang, Sheng-Shun Yang, Hsing-Tao Kuo, Pin-Nan Cheng, Ming-Lung Yu, Pei-Jer Chen
Drug Resistance Profile and Clinical Features for Hepatitis C Patients Experiencing DAA Failure in Taiwan. Viruses 13 (11) (2021)
Hsien-Hong Lin, Shih-Jer Hsu, Sheng-Nan Lu, Wan-Long Chuang, Chao-Wei Hsu, Rong-Nan Chien, Sien-Sing Yang, Wei-Wen Su, Jaw-Ching Wu, Tzong-Hsi Lee, Cheng-Yuan Peng, Kuan-Chiao Tseng, Albert Qin, Yi-Wen Huang, Pei-Jer Chen
Ropeginterferon alfa-2b in patients with genotype 1 chronic hepatitis C: Pharmacokinetics, safety, and preliminary efficacy. JGH open : an open access journal of gastroenterology and hepatology 5 (8) (2021)
Chun-Jen Liu, Pei-Jer Chen
Changing epidemiology of liver disease in Asia: Dual infection of HBV and HCV. Liver international : official journal of the International Association for the Study of the Liver (2021)
Shang-Chin Huang, Hau-Jyun Su, Jia-Horng Kao, Tai-Chung Tseng, Hung-Chih Yang, Tung-Hung Su, Pei-Jer Chen, Chun-Jen Liu
Clinical and Histologic Features of Patients with Biopsy-Proven Metabolic Dysfunction-Associated Fatty Liver Disease. Gut and liver 15 (3) (2021)
Jau-Hau Horng, Wei-Hsiang Lin, Chang-Ru Wu, You-Yu Lin, Li-Ling Wu, Ding-Shinn Chen, Pei-Jer Chen
HBV X protein-based therapeutic vaccine accelerates viral antigen clearance by mobilizing monocyte infiltration into the liver in HBV carrier mice. Journal of biomedical science 27 (1) (2020)
Pei-Jer Chen, Jia-Horng Kao, Chun-Jen Liu, Hung-Chih Yang
In Memoriam: Dr. Ding-Shinn Chen, 1943-2020. Hepatology (Baltimore, Md.) 72 (5) (2020)
Yun-Yuan Chen, Chi-Ling Chen, Jen-Wei Chen, Nien-Tzu Hsu, Sheng-Tang Wei, Sheng-Mou Hou, Sheng-Nan Lu, Pei-Jer Chen
Secular Trends and Geographic Maps of Hepatitis C Virus Infection among 4 Million Blood Donors in Taiwan from 1999 to 2017. Hepatology communications 4 (8) (2020)
Yi-Wen Huang, Chao-Wei Hsu, Sheng-Nan Lu, Ming-Lung Yu, Chien-Wei Su, Wei-Wen Su, Rong-Nan Chien, Ching-Sheng Hsu, Shih-Jer Hsu, Hsueh-Chou Lai, Albert Qin, Kuan-Chiao Tseng, Pei-Jer Chen
Ropeginterferon alfa-2b every 2 weeks as a novel pegylated interferon for patients with chronic hepatitis B. Hepatology international 14 (6) (2020)
Chiao-Ling Li, Ming-Chih Ho, You-Yu Lin, Sheng-Tai Tzeng, Yun-Ju Chen, Hsin-Yung Pai, Ya-Chun Wang, Chi-Ling Chen, Yu-Hsin Lee, Ding-Shinn Chen, Shiou-Hwei Yeh, Pei-Jer Chen
Cell-Free Virus-Host Chimera DNA From Hepatitis B Virus Integration Sites as a Circulating Biomarker of Hepatocellular Cancer. Hepatology (Baltimore, Md.) 72 (6) (2020)
You-Yu Lin, Ming-Whei Yu, Shi-Ming Lin, Shou-Dong Lee, Chih-Ling Chen, Ding-Shinn Chen, Pei-Jer Chen
Genome-wide association analysis identifies a GLUL haplotype for familial hepatitis B virus-related hepatocellular carcinoma. Cancer 123 (20) (2017)

Pei-Jer Chen.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Pei-Jer Chen